z-logo
open-access-imgOpen Access
In vitro development of resistance to DX-619 and other quinolones in enterococci
Author(s) -
Paul A. Wickman,
Jennifer Ann Black,
Ellen Smith Moland,
K. S. Thomson,
Nancy D. Hanson
Publication year - 2006
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkl421
Subject(s) - gatifloxacin , moxifloxacin , quinolone , levofloxacin , ciprofloxacin , microbiology and biotechnology , enterococcus faecalis , ofloxacin , gemifloxacin , mutant , enterococcus faecium , minimum inhibitory concentration , biology , pharmacology , antibiotics , bacteria , staphylococcus aureus , biochemistry , genetics , gene
To investigate the molecular events involved in the development of quinolone resistance in enterococci.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom